Keynote Speaker: Carlos de Castro III, MD
Distinguished hematologist-oncologist Dr. de Castro’s career has been marked by a fervent commitment to excellence, compassion, and ground breaking research. He will share his innovative approach to deepen the understanding of PNH as a paradigm for rare diseases. Don’t miss this opportunity to gain valuable insight into the future of treating challenging blood disorders.
Additional Highlights:
Clinical Quandary: Submit a challenging patient case for our experts to debate. Debate Topics: Amyloidosis, Follicular Lymphoma, CLL novel combinations, racial disparities in AML, DLBCL, and a wide range of hematologic malignancy debates.
25th Annual Duke Debates: Controversies in the Management of Patients with Hematologic Malignancies
Registration open
Professional
Updated
Register online.
